Using the IDEOM Workflow for LCMS-Based Metabolomics Studies of Drug Mechanisms
Authors:
- 18 January 2020
- book chapter
- Published by Springer Nature
- Vol. 2104, 419-445
Abstract
Rapid advancements in metabolomics technologies have allowed for application of liquid chromatography mass spectrometry (LCMS)-based metabolomics to investigate a wide range of biological questions. In addition to an important role in studies of cellular biochemistry and biomarker discovery, an exciting application of metabolomics is the elucidation of mechanisms of drug action (Creek et al., Antimicrob Agents Chemother 60:6650–6663, 2016; Allman et al., Antimicrob Agents Chemother 60:6635–6649, 2016). Although it is a very useful technique, challenges in raw data processing, extracting useful information out of large noisy datasets, and identifying metabolites with confidence, have meant that metabolomics is still perceived as a highly specialized technology. As a result, metabolomics has not yet achieved the anticipated extent of uptake in laboratories around the world as genomics or transcriptomics. With a view to bring metabolomics within reach of a nonspecialist scientist, here we describe a routine workflow with IDEOM, which is a graphical user interface within Microsoft Excel, which almost all researchers are familiar with. IDEOM consists of custom built algorithms that allow LCMS data processing, automatic noise filtering and identification of metabolite features (Creek et al., Bioinformatics 28:1048–1049, 2012). Its automated interface incorporates advanced LCMS data processing tools, mzMatch and XCMS, and requires R for complete functionality. IDEOM is freely available for all researchers and this chapter will focus on describing the IDEOM workflow for the nonspecialist researcher in the context of studies designed to elucidate mechanisms of drug action.Keywords
This publication has 21 references indexed in Scilit:
- High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compoundsScience Translational Medicine, 2018
- Opportunities and challenges in phenotypic drug discovery: an industry perspectiveNature Reviews Drug Discovery, 2017
- Metabolomics-Based Screening of the Malaria Box Reveals both Novel and Established Mechanisms of ActionAntimicrobial Agents and Chemotherapy, 2016
- Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target PathwaysAntimicrobial Agents and Chemotherapy, 2016
- Phenotypic Screens in Antimalarial Drug DiscoveryTrends in Parasitology, 2016
- Untargeted Metabolomics Reveals a Lack Of Synergy between Nifurtimox and Eflornithine against Trypanosoma bruceiPLOS Neglected Tropical Diseases, 2012
- PeakML/mzMatch: A File Format, Java Library, R Library, and Tool-Chain for Mass Spectrometry Data AnalysisAnalytical Chemistry, 2011
- Thousands of chemical starting points for antimalarial lead identificationNature, 2010
- A domino effect in antifolate drug action in Escherichia coliNature Chemical Biology, 2008
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006